caspofungin

Clinical and Pharmacoeconomic Analysis of the Treatment of Invasive Candidiasis in Intensive Care Units

Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(3):264-274
Invasive candidiasis is a third or fourth cause of sepsis in intensive care units (ICUs). Clinical and pharmacoeconomic study of treatment for invasive candidiasis was first performed using mathematical modeling in Russian economic environment. ICU …

Efficacy and Safety of Combined Antimycotic Therapy of Invasive Aspergillosis in Children

Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):383-388
Invasive aspergillosis is a common complication in children with hemoblastosis. This type of mycosis characterized with severe clinical presentations and high attributive mortality. Monotherapy with one of the systemic antimycotics is often using to …

Efficacy and Safety of Caspofungin in Children with Invasive Fungal Infections

Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(2):193-200
The prospective study of 19 children (aged of 1 to 17 years) with invasive fungal infections and different forms of immunosupression was conducted. Clinical and microbiological efficacy and safety of caspofungin, as well as analysis of direct costs …

First Russian Experience of Successful Use of Caspofungin in Invasive Candidiasis in Patient with Severe Hepatic Failure (Clinical case)

Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(4):403-409
A clinical case of the successful use of caspofungin for the treatment of invasive candidiasis, caused by fluconazole- and voriconazole-resistant strain of Candida glabrata, in the patient with severe hepatic failure (Child-Pugh score of 12) due to …